These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

193 related items for PubMed ID: 12359610

  • 1. Intraocular penetration and systemic absorption after topical application of dexamethasone disodium phosphate.
    Weijtens O, Schoemaker RC, Romijn FP, Cohen AF, Lentjes EG, van Meurs JC.
    Ophthalmology; 2002 Oct; 109(10):1887-91. PubMed ID: 12359610
    [Abstract] [Full Text] [Related]

  • 2. High concentration of dexamethasone in aqueous and vitreous after subconjunctival injection.
    Weijtens O, Feron EJ, Schoemaker RC, Cohen AF, Lentjes EG, Romijn FP, van Meurs JC.
    Am J Ophthalmol; 1999 Aug; 128(2):192-7. PubMed ID: 10458175
    [Abstract] [Full Text] [Related]

  • 3. Peribulbar corticosteroid injection: vitreal and serum concentrations after dexamethasone disodium phosphate injection.
    Weijtens O, van der Sluijs FA, Schoemaker RC, Lentjes EG, Cohen AF, Romijn FP, van Meurs JC.
    Am J Ophthalmol; 1997 Mar; 123(3):358-63. PubMed ID: 9063245
    [Abstract] [Full Text] [Related]

  • 4. Penetration of ofloxacin in human aqueous and vitreous humors following oral and topical administration.
    Cekic O, Batman C, Yasar U, Basci NE, Bozkurt A, Kayaalp SO.
    Retina; 1998 Mar; 18(6):521-5. PubMed ID: 9869460
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Dexamethasone concentration in the subretinal fluid after a subconjunctival injection, a peribulbar injection, or an oral dose.
    Weijtens O, Schoemaker RC, Lentjes EG, Romijn FP, Cohen AF, van Meurs JC.
    Ophthalmology; 2000 Oct; 107(10):1932-8. PubMed ID: 11013202
    [Abstract] [Full Text] [Related]

  • 7. Dexamethasone concentration in vitreous and serum after oral administration.
    Weijtens O, Schoemaker RC, Cohen AF, Romijn FP, Lentjes EG, van Rooij J, van Meurs JC.
    Am J Ophthalmol; 1998 May; 125(5):673-9. PubMed ID: 9625551
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Intracorneal, aqueous humor, and vitreous humor penetration of topical and oral ofloxacin.
    Donnenfeld ED, Perry HD, Snyder RW, Moadel R, Elsky M, Jones H.
    Arch Ophthalmol; 1997 Feb; 115(2):173-6. PubMed ID: 9046250
    [Abstract] [Full Text] [Related]

  • 10. Human intraocular penetration pharmacokinetics of moxifloxacin 0.5% via topical and collagen shield routes of administration.
    Hariprasad SM, Mieler WE, Shah GK, Blinder KJ, Apte RS, Holekamp NM, Thomas MA, Chi J, Prince RA.
    Trans Am Ophthalmol Soc; 2004 Feb; 102():149-55; discussion 155-7. PubMed ID: 15747753
    [Abstract] [Full Text] [Related]

  • 11. Ocular absorption of dexamethasone phosphate disodium by the rabbit.
    Rosenblum C, Dengler RE, Geoffroy RF.
    Arch Ophthalmol; 1967 Feb; 77(2):234-7. PubMed ID: 6019020
    [No Abstract] [Full Text] [Related]

  • 12. Vitreous and aqueous concentrations of brimonidine following topical application of brimonidine tartrate 0.1% ophthalmic solution in humans.
    Takamura Y, Tomomatsu T, Matsumura T, Takihara Y, Kozai S, Arimura S, Yokota S, Inatani M.
    J Ocul Pharmacol Ther; 2015 Jun; 31(5):282-5. PubMed ID: 25918904
    [Abstract] [Full Text] [Related]

  • 13. Intraocular dexamethasone penetration via subconjunctival or retrobulbar injections in rabbits.
    Bodker FS, Ticho BH, Feist RM, Lam TT.
    Ophthalmic Surg; 1993 Jul; 24(7):453-7. PubMed ID: 8351091
    [Abstract] [Full Text] [Related]

  • 14. Penetration pharmacokinetics of topically administered 0.5% moxifloxacin ophthalmic solution in human aqueous and vitreous.
    Hariprasad SM, Blinder KJ, Shah GK, Apte RS, Rosenblatt B, Holekamp NM, Thomas MA, Mieler WF, Chi J, Prince RA.
    Arch Ophthalmol; 2005 Jan; 123(1):39-44. PubMed ID: 15642810
    [Abstract] [Full Text] [Related]

  • 15. Penetration of a topically administered anti-tumor necrosis factor alpha antibody fragment into the anterior chamber of the human eye.
    Thiel MA, Wild A, Schmid MK, Job O, Bochmann F, Loukopoulos V, Alcantara W, Schmidt A, Lichtlen P, Escher D.
    Ophthalmology; 2013 Jul; 120(7):1403-8. PubMed ID: 23490328
    [Abstract] [Full Text] [Related]

  • 16. Aqueous and vitreous penetration of levofloxacin after topical and/or oral administration.
    Sakamoto H, Sakamoto M, Hata Y, Kubota T, Ishibashi T.
    Eur J Ophthalmol; 2007 Jul; 17(3):372-6. PubMed ID: 17534819
    [Abstract] [Full Text] [Related]

  • 17. [Ocular penetration of dexamethasone sodium phosphate via soft contact lenses].
    Goto S, Fujiwara H, Egi K, Katayama T, Suzuki T.
    Nippon Ganka Gakkai Zasshi; 1989 Feb; 93(2):254-7. PubMed ID: 2788978
    [Abstract] [Full Text] [Related]

  • 18. Aqueous humour concentrations after topical apPlication of combinEd levofloxacin-dexamethasone eye dRops and of its single components: a randoMised, assEssor-blinded, parallel-group study in patients undergoing cataract surgery: the iPERME study.
    Figus M, Posarelli C, Romano D, Nardi M, Rossetti L.
    Eur J Clin Pharmacol; 2020 Jul; 76(7):929-937. PubMed ID: 32285142
    [Abstract] [Full Text] [Related]

  • 19. Ofloxacin penetration into the eye after intravenous and topical administration.
    Fiscella RG, Shapiro MJ, Solomon MJ, Kurtz RM, Mui S, Labib S.
    Retina; 1997 Jul; 17(6):535-9. PubMed ID: 9428017
    [Abstract] [Full Text] [Related]

  • 20. Vitreous and aqueous penetration of orally administered gatifloxacin in humans.
    Hariprasad SM, Mieler WF, Holz ER.
    Arch Ophthalmol; 2003 Mar; 121(3):345-50. PubMed ID: 12617704
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.